The Food and Drug Administration (FDA) could use data it has collected from millions of suspected drug-related adverse event reports and other electronic medical information to identify a pattern of adverse drug events in a specific population. The agency could then communicate this knowledge sooner to medical professionals and patients. This data collected by the FDA would be held in a(n) ____.
Internet database
competitive intelligence source
data warehouse
data extraction
information clearinghouse